Home Children Tags

View the Latest: Children

Filter

List Grid

161 - 170 of 383 Results

  • SCHIP Reauthorization: Key Questions in the Debate – A Description of New Administrative Guidance and the House and Senate Proposals – Issue Brief

    Issue Brief

    SCHIP Reauthorization: Key Questions in the Debate – A Description of New Administrative Guidance and the House and Senate Proposals The U.S. Senate and the House of Representatives have approved legislation to reauthorize the State Children's Health Insurance Program (SCHIP), which covers six million low-income children today. With the release of the Census health coverage numbers, this updated brief answers key questions that explain the ongoing policy debate about this public health coverage program, which…

  • Why Express Lane Eligibility Makes Sense for States and Low-Income Families

    Issue Brief

    Express Lane Eligibility (ELE) is a new tool available to states to streamline enrollment and renewal of children in Medicaid and CHIP. It allows state Medicaid and CHIP agencies to utilize data and eligibility findings from other public need-based programs, such as Head Start or Food Stamps, and/or tax return data to identify, enroll and recertify children rather than requiring them to re-analyze and determine eligibility under their own rules. This issue brief, one in…

  • Vaccine Monitor: 6 in 10 Parents of Teens and One-Third of Parents of 5-11 Year-Olds Say Their Child is Vaccinated for COVID-19, Both Up Since November

    News Release

    3 in 10 of Those with Children Under 5 Expect to Get Them a Shot Right Away Once Eligible 1 in 4 Parents Say Their Student Had to Quarantine in January Due to COVID-19 Infection or Exposure; Overall 4 in 10 Report Some Education Disruption Growing shares of parents say that their eligible children have gotten at least one dose of a COVID-19 vaccine, and three in ten parents with children under age 5 say…

  • The Last Major Phase of the COVID-19 Vaccination Roll-out: Children Under 5

    Issue Brief

    With the FDA authorization of both Moderna and Pfizer’s COVID-19 vaccine for children between the ages of 6 months and 5, the last major phase of the U.S. vaccination roll-out is underway. This brief provides an overview of the characteristics of children under the age of 5 and discusses some issues to consider in rolling out vaccination to this age group.

  • Diversity of Under-5 Age Group Varies Across States

    Feature

    Of the 19 million U.S. children under 5, half are children of color, making this group more diverse than the U.S. population overall. There is also significant variation across the country.

  • KFF COVID-19 Vaccine Monitor: February 2022

    Poll Finding

    Two years into the COVID-19 pandemic, the public is split on their readiness to return to normal, with many worried about the consequences of lifting restrictions and of not lifting them. At this point, the pandemic is not a top issue for voters in November's midterm elections . Most parents are not confident in the safety of the vaccine for kids under 5.

  • KFF/The Washington Post Survey of Parents: Polling Insights on the MAHA Movement

    Poll Finding

    These findings from the KFF/Washington Post Survey of Parents shed light on parents who support the Make America Healthy Again movement, including the issues they see as top concerns for their children's wellbeing and their attitudes when it comes to vaccines and government regulations on food.

  • KFF/Washington Post Poll Looks at Parents’ Trust in Children’s Health Content on Social Media, And Unfounded Claims About Abortion Pill Safety Follow FDA Approval of Generic Version – The Monitor

    Feature

    This volume shares findings from the KFF/The Washington Post Survey of Parents about exposure to and trust in children’s health content on social media, along with misleading claims following the approval of a generic version of mifepristone, reports of autism possibly being added to the Vaccine Injury Compensation Program, and patients using AI chatbots to interpret lab results.

  • How Schools Have Responded to the Youth Fentanyl Crisis

    Issue Brief

    With the onset of the COVID-19 pandemic, deaths due to drug overdose among adolescents more than doubled, primarily driven by the synthetic opioid, fentanyl. National survey data show that while the percent of adolescents (ages 12-17) with a past year substance use disorder decreased from 2021 to 2024, the share of adolescents with a past year opioid use disorder remained stable over the same period. Additionally, less than one-third of adolescents with a past year opioid use…